Jim Howard is a 24-year transformative healthtech leader focused on disruptive, first-to-market commercialization. He co-founded and capitalized SentiAR to pull the technology out of Washington University in 2017 after leading the commercialization of Washington University’s clinical genomic software in 2015. He led a 60-person commercial team at CareFusion until the BD acquisition in 2015 and has had two other start-up exits in healthcare IT and biotech. Jim is and investor and director at MagBiosense, another St. Louis-based cardiology device start-up.
The startups whose pitches have been accepted are currently fundraising in order to launch their companies and solve problems in XR; they’re looking for investments, corporate customers and strategic partners. Funds from around the world are represented at the event, looking to discover frontier technology and identify new investment opportunities.